FDA’s ‘Green List’ for Safe GLP-1 Drug Imports
The FDA created a 'green list' to block potentially harmful GLP-1 APIs from unverified foreign sources. WHO also updated essential medicine lists, including obesity and diabetes treatments. Regulators tighten compounded medicine rules.